— Know what they know.
Not Investment Advice

REMI OTC

Remedent, Inc.
1W: +0.0% 1M: +14.3% 3M: +14.3% YTD: +33.3% 1Y: +300.0% 3Y: -99.5% 5Y: -99.4%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 63 · $15997 mcap · 13M float · 0.050% daily turnover · Short 98% of daily vol

Income Trends

Revenue
$986K +14.2% ▲
5Y CAGR: -9.3%
Gross Profit
$603K +19.3% ▲
5Y CAGR: -10.0%
Operating Income
-$123K +56.6% ▲
Net Income
-$274K +81.6% ▲
EPS (Diluted)
$-0.01 +81.7% ▲
EBITDA
-$215K +85.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$1M$1M$1M$864K$986K
YoY Growth-33.6%-3.2%+36.7%-38.6%+14.2%
Cost of Revenue$322K$451K$361K$358K$383K
Gross Profit$742K$579K$1M$506K$603K
Gross Margin69.7%56.2%74.4%58.5%61.2%
R&D Expenses$0$0$15K$0$152
SG&A Expenses$1M$611K$715K$789K$726K
Operating Expenses$1M$611K$729K$789K$726K
Operating Income-$480K-$32K$317K-$283K-$123K
Operating Margin-45.1%-3.1%22.6%-32.8%-12.5%
Interest Expense$14K$4K$7K$4K$0
Income Before Tax-$852K-$141K-$190K-$1M-$235K
Tax Expense$2K$3K$23K$18K$17K
Net Income-$854K-$163K-$257K-$1M-$274K
Net Margin-80.3%-15.8%-18.3%-173.0%-27.8%
EPS (Diluted)$-0.04$-0.01$-0.01$-0.07$-0.01
EBITDA-$767K-$102K-$154K-$1M-$215K
Shares Outstanding20M20M20M20M20M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms